pathology microbiology and immunology Archives
Cassat lands Burroughs Wellcome Fund award
Jul. 31, 2014—James Cassat, M.D., Ph.D., assistant professor of Pediatrics and Pathology, Microbiology and Immunology, has received a Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
New target for breast cancer therapy
Jul. 31, 2014—The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics.
Treatments for frog fungus
Jul. 25, 2014—The fungicide amphotericin B may be a useful treatment for a frog fungus that is killing amphibians worldwide.
Natural killer cells don’t clear HMPV
Jul. 23, 2014—Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.
Neural receptor for reovirus
Jul. 18, 2014—A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.
Regulating immune regulators
Jul. 17, 2014—Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.
Study finds ‘hot’ frogs fight off fungal pathogen
Jul. 9, 2014—Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.
Respiratory virus vaccine candidate
May. 27, 2014—Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.
Target cell entry to halt Chikungunya virus
Apr. 28, 2014—Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.
Anthrax bacteria’s signaling systems
Apr. 15, 2014—Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.
Flu boosts pneumococcal colonization
Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.
Infection research symposium set for April 11
Mar. 20, 2014—The latest research on pneumonic plague, respiratory syncytial virus (RSV) and other life-threatening infections will be discussed during a Symposium on Infection and Immunity April 11 at the Vanderbilt Student Life Center.
